Search Media Items

Immunotherapy is treatment that helps your immune system fight cancer. Get information about the different types of immunotherapy and what you can expect during treatment.

Information to help people evaluate the source and credibility of health information that they find in print or online.

Read about how NCI is working to reduce cancer disparities by bringing clinical trials to minority and underserved communities.

Medicamento experimental es el evaluado en laboratorios y en animales y aprobado por la FDA de EE. UU. para probarse en personas, pero no puede anunciarse, venderse o recetarse. Medicamentos experimentales pueden estar disponibles por estudios clínicos o por programas de extensión de acceso. Aprenda más.

Human tumor atlases act as maps that describe the multidimensional cellular, structural, and molecular characteristics of human cancers over time. This information will improve understanding of how cancers develop and respond to treatment, ultimately improving care.

Despite significant progress in the treatment of breast cancer, the transition of pre-invasive ductal carcinoma in situ (DCIS) to more aggressive invasive ductal carcinoma (IDC) remains unknown. No prognostic biomarkers can reliably predict the risk of progression from DCIS to IDC. Similar genomic profiles of matched pre-invasive DCIS and IDC suggests that the progression is not driven by genetic aberrations in DCIS cells, but microenvironmental factors, such as hypoxia and metabolic stress prevalent in DCIS, may drive the transition.

Surgery, when used to treat cancer, is a procedure in which a surgeon removes cancer from your body. Learn how surgery is performed and different types of surgery.

Information about the ways in which clinical trial participants are protected before and during the conduct of a study.

Information to help people think about whether taking part in a cancer clinical trial is right for them. Covers benefits and risks of taking part, as well as eligibility criteria.

Information about how the rights and safety of people who take part in clinical trials are protected.